UB Paderborn / Katalog / Suche / in CDI

Gastrointestinal Complications in Liver Transplant Recipients: MITOS Study

Transplantation proceedings, 2007-09, Vol.39 (7), p.2311-2313

2007

Link zum Volltext

Verfügbarkeit prüfen

360 APPLICATION OF RESTRICTIVE SELECTION CRITERIA IMPROVES SURVIVAL OF HEPATOCELLULAR CARCINOMA TREATED BY MEANS OF PERCUTANEOUS ABLATION

Journal of hepatology, 2008, Vol.48, p.S141-S141

2008

Link zum Volltext

Verfügbarkeit prüfen

361 EFFICACY OF SEQUENTIAL TRANSARTERIAL CHEMOEMBOLIZATION PLUS PERCUTANEOUS ETHANOL INJECTION FOR THE TREATMENT OF INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA: RESULTS OF A PILOT STUDY

Journal of hepatology, 2008, Vol.48, p.S141-S141

2008

Link zum Volltext

Verfügbarkeit prüfen

362 SHORT-TERM EFFICACY AND SAFETY OF TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA WITH SORAFENIB

Journal of hepatology, 2008, Vol.48, p.S141-S142

2008

Link zum Volltext

Verfügbarkeit prüfen

359 GRADE OF DIFFERENTIATION AND TUMOR CAPSULE PREDICT THE LOCAL THERAPEUTIC RESPONSE OF HEPATOCELLULAR CARCINOMA TO PERCUTANEOUS ETHANOL INJECTION: RESULTS OF A PROSPECTIVE STUDY

Journal of hepatology, 2008, Vol.48, p.S140-S141

2008

Link zum Volltext

Verfügbarkeit prüfen

Calcineurin Inhibitors in Liver Transplantation: To Be or Not to Be

Transplantation proceedings, 2011-07, Vol.43 (6), p.2220-2223

2011

Link zum Volltext

Verfügbarkeit prüfen

Differences in the Incidence and Clinical Evolution of Early Neurotoxicity After Liver Transplantation Based on Tacrolimus Formulation Used in the Immunosuppressive Induction Protocol

Transplantation proceedings, 2014-11, Vol.46 (9), p.3117-3120

2014

Link zum Volltext

Verfügbarkeit prüfen

Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Is an Active Surveillance for Recurrence Needed?

Transplantation proceedings, 2012-07, Vol.44 (6), p.1565-1567

2012

Link zum Volltext

Verfügbarkeit prüfen

The Future of Liver Transplantation

Transplantation proceedings, 2010-03, Vol.42 (2), p.613-616

2010

Link zum Volltext

Verfügbarkeit prüfen

Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events

Journal of hepatology, 2016, Vol.64 (2), p.S319-S319

2016

Link zum Volltext

Verfügbarkeit prüfen

Improvement of Renal Function After Conversion to Mycophenolate Mofetil Combined With Low-Level Calcineurin Inhibitor in Liver Transplant Recipients With Chronic Renal Dysfunction

Transplantation proceedings, 2010-03, Vol.42 (2), p.656-659

2010

Link zum Volltext

Verfügbarkeit prüfen

Strategies of Immunosuppression for Liver Transplant Recipients With Hepatocellular Carcinoma

Transplantation proceedings, 2011-04, Vol.43 (3), p.711-713

2011

Link zum Volltext

Verfügbarkeit prüfen

Safety of an Immunosuppressant Protocol Based on Sirolimus in Liver Transplant Recipients With Malignancies or High Risk of Tumor Recurrence

Transplantation proceedings, 2009-04, Vol.41 (3), p.1003-1004

2009

Link zum Volltext

Verfügbarkeit prüfen

“Very Early” Intrahepatic Cholangiocarcinoma in Cirrhotic Patients: Should Liver Transplantation Be Reconsidered in These Patients?

American journal of transplantation, 2014-03, Vol.14 (3), p.660-667

2014

Link zum Volltext

Verfügbarkeit prüfen

Orthotopic Liver Transplantation for Hepatocellular Carcinoma: A Thirteen-Year Single-Center Experience

Transplantation proceedings, 2008-11, Vol.40 (9), p.2975-2977

2008

Link zum Volltext

Verfügbarkeit prüfen

Prospective Histopathological Analysis of Hepatocellular Carcinoma Treated With Percutaneous Ethanol Injection in Patients on the Waiting List for Liver Transplantation

Transplantation proceedings, 2005-04, Vol.37 (3), p.1477-1479

2005

Link zum Volltext

Verfügbarkeit prüfen

Doppler Ultrasonography for the Assessment of Tumor Necrosis After Percutaneous Ethanol Injection Prior to Liver Transplantation as Adjuvant Therapy of Hepatocellular Carcinoma

Transplantation proceedings, 2005-04, Vol.37 (3), p.1493-1495

2005

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy

Transplantation proceedings, 2002-08, Vol.34 (5), p.1553-1554

2002

Link zum Volltext

Verfügbarkeit prüfen

THU-038 - Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events

Journal of hepatology, 2016, Vol.64 (2), p.S319-S319

2016

Link zum Volltext

Verfügbarkeit prüfen

Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra–low dose tacrolimus and basiliximab

Transplantation proceedings, 2002-08, Vol.34 (5), p.1533-1534

2002

Link zum Volltext

Verfügbarkeit prüfen

Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus

Transplantation proceedings, 2002-08, Vol.34 (5), p.1567-1568

2002

Link zum Volltext

Verfügbarkeit prüfen

Prospective Interventional Study to Evaluate the Efficacy and Safety of Liposomal Amphotericin B as Prophylaxis of Fungal Infections in High-Risk Liver Transplant Recipients

Transplantation proceedings, 2005-11, Vol.37 (9), p.3965-3967

2005

Link zum Volltext

Verfügbarkeit prüfen

Utility of ambulatory blood pressure monitoring for diagnosis of hypertension in liver allograft recipients

Transplantation proceedings, 2003-03, Vol.35 (2), p.718-718

2003

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Liver Disease in Patients with Streptococcus bovis Bacteraemia

The Journal of infection, 2001-02, Vol.42 (2), p.116-119

2001

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Gastrointestinal Complications in Liver Transplant Recipients: MITOS Study

269 INTRAHEPATIC CHOLANGIOCARCINOMA (I-CC) OR MIXED HEPATOCELLULAR–CHOLANGIOCARCINOMA (HCC-CC) IN PATIENTS UNDERGOING LIVER TRANSPLANTATION. A SPANISH CASE CONTROL MULTICENTER STUDY

360 APPLICATION OF RESTRICTIVE SELECTION CRITERIA IMPROVES SURVIVAL OF HEPATOCELLULAR CARCINOMA TREATED BY MEANS OF PERCUTANEOUS ABLATION

361 EFFICACY OF SEQUENTIAL TRANSARTERIAL CHEMOEMBOLIZATION PLUS PERCUTANEOUS ETHANOL INJECTION FOR THE TREATMENT OF INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA: RESULTS OF A PILOT STUDY

362 SHORT-TERM EFFICACY AND SAFETY OF TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA WITH SORAFENIB

359 GRADE OF DIFFERENTIATION AND TUMOR CAPSULE PREDICT THE LOCAL THERAPEUTIC RESPONSE OF HEPATOCELLULAR CARCINOMA TO PERCUTANEOUS ETHANOL INJECTION: RESULTS OF A PROSPECTIVE STUDY

Calcineurin Inhibitors in Liver Transplantation: To Be or Not to Be

Differences in the Incidence and Clinical Evolution of Early Neurotoxicity After Liver Transplantation Based on Tacrolimus Formulation Used in the Immunosuppressive Induction Protocol

Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Is an Active Surveillance for Recurrence Needed?

The Future of Liver Transplantation

Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events

Improvement of Renal Function After Conversion to Mycophenolate Mofetil Combined With Low-Level Calcineurin Inhibitor in Liver Transplant Recipients With Chronic Renal Dysfunction

Strategies of Immunosuppression for Liver Transplant Recipients With Hepatocellular Carcinoma

Safety of an Immunosuppressant Protocol Based on Sirolimus in Liver Transplant Recipients With Malignancies or High Risk of Tumor Recurrence

“Very Early” Intrahepatic Cholangiocarcinoma in Cirrhotic Patients: Should Liver Transplantation Be Reconsidered in These Patients?

Orthotopic Liver Transplantation for Hepatocellular Carcinoma: A Thirteen-Year Single-Center Experience

Prospective Histopathological Analysis of Hepatocellular Carcinoma Treated With Percutaneous Ethanol Injection in Patients on the Waiting List for Liver Transplantation

Doppler Ultrasonography for the Assessment of Tumor Necrosis After Percutaneous Ethanol Injection Prior to Liver Transplantation as Adjuvant Therapy of Hepatocellular Carcinoma

Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy

THU-038 - Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events

Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra–low dose tacrolimus and basiliximab

Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus

Prospective Interventional Study to Evaluate the Efficacy and Safety of Liposomal Amphotericin B as Prophylaxis of Fungal Infections in High-Risk Liver Transplant Recipients

Utility of ambulatory blood pressure monitoring for diagnosis of hypertension in liver allograft recipients

Prevalence of Liver Disease in Patients with Streptococcus bovis Bacteraemia

Suchergebnisse filtern